Ratings by Raymond James (Michael Freeman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Dyne Therapeutics | DYN | Maintain | Strong Buy (N/A) |
|
Details | ||
| 2/2/2026 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2026 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/7/2026 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2025 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2025 | Dyne Therapeutics | DYN | Maintain | Strong Buy (N/A) |
|
Details | ||
| 10/27/2025 | Avidity Biosciences | RNA | Downgrade | Market Perform (Strong Buy) |
48.55 (14.82) |
-69.47% | Details | |
| 10/17/2025 | Disc Medicine | IRON | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/25/2025 | Profound Medical Corp. | PROF | Maintain | Outperform (N/A) |
|
Details | ||
| 9/10/2025 | Avidity Biosciences | RNA | Maintain | Strong Buy (N/A) |
|
Details | ||
| 9/3/2025 | WAVE Life Sciences | WVE | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | Dyne Therapeutics | DYN | Upgrade | Strong Buy (Outperform) |
12.58 (14.86) |
18.12% | Details | |
| 7/29/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/18/2025 | Disc Medicine | IRON | Maintain | Strong Buy (N/A) |
|
Details | ||
| 6/11/2025 | WAVE Life Sciences | WVE | New Coverage | Outperform (N/A) |
7.05 (13.12) |
86.1% | Details | |
| 6/11/2025 | Tectonic Therapeutics Inc. | TECX | New Coverage | Outperform (N/A) |
24.48 (35.87) |
46.53% | Details | |
| 6/11/2025 | Dyne Therapeutics | DYN | New Coverage | Outperform (N/A) |
14.40 (12.58) |
-12.64% | Details | |
| 6/11/2025 | Disc Medicine | IRON | New Coverage | Strong Buy (N/A) |
51.42 (61.18) |
18.98% | Details | |
| 6/11/2025 | Avidity Biosciences | RNA | New Coverage | Strong Buy (N/A) |
32.66 (48.55) |
48.65% | Details | |
| 5/9/2025 | Profound Medical Corp. | PROF | Downgrade | Outperform (Strong Buy) |
4.98 (5.31) |
6.63% | Details | |
| 5/5/2025 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/19/2025 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/10/2024 | Bausch Health Companies | BHC | New Coverage | Market Perform (N/A) |
7.19 (5.38) |
-25.17% | Details |
